Biomanufacturing Media

  1. Viral Clearance Strategies For Monoclonal Antibodies And Proteins 1/30/2026

    Guidance on designing viral clearance studies using regulatory-aligned, risk‑based strategies, optimized assays, and real case examples for safe, efficient biologics development.

  2. Drug Product Development: Preclinical To Commercial 1/26/2026

    Watch a unified roadmap for drug product development, outlining phase‑appropriate studies, QTTP importance, and key requirements from preclinical stages through commercialization.

  3. Developability Assessment And Early Formulation Studies 1/26/2026

    Early developability and pre‑formulation screening build strong biophysical data, reduce late‑stage risks, support candidate selection, and streamline biologics development toward clinical success.

  4. Five Practical Considerations To Move From Concept To Clinic 12/17/2025

    Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.

  5. Hear From The Experts: LNPs Driving The Future Of Cell Therapy 12/12/2025

    Explore how lipid nanoparticles are driving breakthroughs in cell therapy, from mRNA-based immune cell engineering to genome editing for CAR T cells and HSPCs from leading experts.

  6. Manufacturing Made More Robust And Customer-Centric 12/11/2025

    Discover how regional manufacturing, risk-aware practices, and agile strategies are reshaping supply chains to deliver resilience, transparency, and sustainability in today’s complex global environment.

  7. Interesting Questions And Opportunities In Cell Therapy Development 12/10/2025

    Key challenges in emerging cell therapies include finding new antigens, reducing variability, and standardizing processes. Experts also examine response differences in solid versus liquid tumors.

  8. Studying Antigen Escape In B-ALL 12/10/2025

    Researchers uncovered a mechanism of antigen escape linked to low Ikaros expression in tumor cells, offering insights into CAR-T treatments. Explore how multi-omic analysis enabled this discovery.

  9. Building An Oral Vaccine Platform With Vaxart's Sean Tucker, Ph.D. 12/2/2025

    In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Sean Tucker, Ph.D., founder and chief scientific officer at Vaxart, a company developing oral recombinant pill vaccines.

  10. The mRNA Journey: From Design To LNP-Ready Molecules For Research 11/25/2025

    Learn a validated, end-to-end protocol for producing high-quality in vitro transcription (IVT) mRNA for preclinical research. Find out how to optimize sequence design, small-scale synthesis, and more.